Related Experiment Videos
Transforming growth factor beta (TGF-B) stimulation of angiogenesis: an electron microscopic study
G D Phillips1, R A Whitehead, A M Stone
1Department of Surgery, University of Minnesota, Minneapolis.
Summary
Transforming growth factor beta (TGF-B) triggers corneal angiogenesis by recruiting inflammatory cells and forming new capillaries from limbal venules. This study visualizes the process using advanced microscopy techniques.
Area of Science:
- Ophthalmology
- Vascular Biology
- Cell Biology
Background:
- Corneal neovascularization is a significant cause of vision impairment.
- Understanding the molecular mechanisms driving angiogenesis is crucial for developing therapeutic strategies.
- Transforming growth factor beta (TGF-B) is implicated in angiogenesis, but its precise role in corneal neovascularization requires detailed investigation.
Purpose of the Study:
- To investigate the initiation and pattern of corneal angiogenesis induced by TGF-B.
- To elucidate the cellular and vascular changes during TGF-B-stimulated corneal neovascularization.
Main Methods:
- Utilized transforming growth factor beta (TGF-B) loaded onto a slow-release polymer (Hydron) implanted in rabbit corneas.
- Employed transmission electron microscopy (TEM) to examine cellular infiltration at 2 and 7 days post-implantation.
- Applied scanning electron microscopy (SEM) on vascular corrosion casts to visualize the neovascularization pattern.
Main Results:
- TEM revealed significant inflammatory cell infiltration, primarily neutrophils, at 2 days post-implantation.
- By 7 days, inflammation subsided, and new capillaries were observed within the corneal stroma.
- SEM demonstrated leukocyte margination/diapedesis from limbal venules at 2 days and showed new vessels originating solely from limbal venules at 7 days.
Conclusions:
- TGF-B induces corneal angiogenesis through an inflammatory cell-mediated process.
- Neovascularization originates from existing limbal vasculature.
- The findings provide insights into the dynamics of corneal neovascularization and potential therapeutic targets.